Clinical Trials (PDQ®) - National Cancer Institute

Page Options

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp online chat

	NCI Highlights


	Maintenance Rituximab for Follicular Lymphoma Azacitidine Improves Survival in MDS Second Stem Cell Transplant Not Helpful in Myeloma

	Related Links


	Educational Materials About Clinical Trials Clinical Trials: Questions and Answers Questions to Ask Your Doctor Drug Information from MedlinePlus

High Risk Breast Cancer Screening Program

Basic Trial Information
Trial Description
Summary
Eligibility Criteria
Trial Contact Information

Basic Trial Information

Phase Type Status Age Sponsor Protocol IDs
No phase specified Natural history/Epidemiology, Screening Approved-not yet active 40 and over Other OOTR-SBR001
NCT00509509

Trial Description

Summary

Objectives:

To screen population with high risk for breast cancer

To promote the concept and importance of surveillance mammography

To find out the incidence of breast cancer in population who are in high risk for breast cancer

To collect blood samples for molecular analysis

Eligibility Criteria

Inclusion Criteria:

Female

> 40 years of age

Women who have first-degree relative suffered from breast cancer

Women who have first-degree relative suffered from ovarian cancer

Family history of male breast cancer

Family history of breast cancer (not necessarily first degree relatives) diagnosed before age of 40

Family history of breast cancer (not necessarily first degree relatives) affecting 2 or more family members

Personal history of ovarian cancer

Personal history of premalignant conditions of breast and ovary

Exclusion Criteria:

Women with mammogram within one year

Trial Contact Information

Trial Lead Organizations/Sponsors

Organisation for Oncology and Translational Research

Louis WC Chow

Principal Investigator

Louis WC Chow		Ph: (852)2861 0286
		Email: lwcchow@unimed.hk

Link to the current ClinicalTrials.gov record.
NLM Identifer NCT00509509
Information obtained from ClinicalTrials.gov on October 20, 2008

Note: Information about this trial is from the ClinicalTrials.gov database. The versions designated for health professionals and patients contain the same text. Minor changes may be made to the ClinicalTrials.gov record to standardize the names of study sponsors, sites, and contacts. Cancer.gov only lists sites that are recruiting patients for active trials, whereas ClinicalTrials.gov lists all sites for all trials. Questions and comments regarding the presented information should be directed to ClinicalTrials.gov.